Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Enhancing vaccine safety capacity globally: A lifecycle perspective.

Chen RT, Shimabukuro TT, Martin DB, Zuber PL, Weibel DM, Sturkenboom M.

Vaccine. 2015 Nov 27;33 Suppl 4:D46-54. doi: 10.1016/j.vaccine.2015.06.073. Epub 2015 Oct 1. Review.

2.

Application of "Systems Vaccinology" to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines.

Lewis DJ, Lythgoe MP.

J Immunol Res. 2015;2015:909406. doi: 10.1155/2015/909406. Epub 2015 Aug 25. Review.

3.

OAE: The Ontology of Adverse Events.

He Y, Sarntivijai S, Lin Y, Xiang Z, Guo A, Zhang S, Jagannathan D, Toldo L, Tao C, Smith B.

J Biomed Semantics. 2014 Jul 5;5:29. doi: 10.1186/2041-1480-5-29. eCollection 2014.

4.

Safe and cost-effective control of post-transplantation recurrence of hepatitis B.

Takaki A, Yagi T, Yamamoto K.

Hepatol Res. 2015 Jan;45(1):38-47. doi: 10.1111/hepr.12368. Epub 2014 Jul 18.

5.

Children who received PCV-10 vaccine from a two-dose vial without preservative are not more likely to develop injection site abscess compared with those who received pentavalent (DPT-HepB-Hib) vaccine: a longitudinal multi-site study.

Berhane Y, Worku A, Demissie M, Tesfaye N, Asefa N, Aniemaw W, Weldearegawi B, Kebede Y, Shiferaw T, Worku A, Olijira L, Merdekios B, Ashebir Y, Tadesse T, Dessie Y, Meseret S, Ayele G.

PLoS One. 2014 Jun 4;9(6):e97376. doi: 10.1371/journal.pone.0097376. eCollection 2014.

6.
8.

Biomarkers in Japanese encephalitis: a review.

Kant Upadhyay R.

Biomed Res Int. 2013;2013:591290. doi: 10.1155/2013/591290. Epub 2013 Dec 18. Review.

9.

Annual report on adverse events related with vaccines use in Calabria (Italy): 2012.

Staltari O, Cilurzo F, Caroleo B, Greco A, Corasaniti F, Genovesi MA, Gallelli L.

J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S61-5. doi: 10.4103/0976-500X.120951.

11.

The role of media and the Internet on vaccine adverse event reporting: a case study of human papillomavirus vaccination.

Eberth JM, Kline KN, Moskowitz DA, Montealegre JR, Scheurer ME.

J Adolesc Health. 2014 Mar;54(3):289-95. doi: 10.1016/j.jadohealth.2013.09.005. Epub 2013 Nov 17.

12.

Motor palsies of cranial nerves (excluding VII) after vaccination: reports to the US Vaccine Adverse Event Reporting System.

Woo EJ, Winiecki SK, Ou AC.

Hum Vaccin Immunother. 2014;10(2):301-5. doi: 10.4161/hv.27032. Epub 2013 Nov 14.

13.

Vaccine adverse events reported during the first ten years (1998-2008) after introduction in the state of Rondonia, Brazil.

Cunha MP, Dórea JG, Marques RC, Leão RS.

Biomed Res Int. 2013;2013:853083. doi: 10.1155/2013/853083. Epub 2013 Feb 14.

14.

Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.

Hu Y, Li Q, Lin L, Chen E, Chen Y, Qi X.

Clin Vaccine Immunol. 2013 Feb;20(2):211-7. doi: 10.1128/CVI.00541-12. Epub 2012 Dec 12.

15.

Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010.

Goldman GS, Miller NZ.

Hum Exp Toxicol. 2012 Oct;31(10):1012-21. doi: 10.1177/0960327112440111. Epub 2012 Apr 24. Erratum in: Hum Exp Toxicol. 2012 Nov;31(11):1190.

16.

Emerging vaccine informatics.

He Y, Rappuoli R, De Groot AS, Chen RT.

J Biomed Biotechnol. 2010;2010:218590. doi: 10.1155/2010/218590. Epub 2011 Jun 15. Review.

17.

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Greene SK, Kulldorff M, Lewis EM, Li R, Yin R, Weintraub ES, Fireman BH, Lieu TA, Nordin JD, Glanz JM, Baxter R, Jacobsen SJ, Broder KR, Lee GM.

Am J Epidemiol. 2010 Jan 15;171(2):177-88. doi: 10.1093/aje/kwp345. Epub 2009 Dec 4.

18.

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C.

Lancet. 2009 Dec 19;374(9707):2115-22. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31. Erratum in: Lancet. 2010 Jan 30;375(9712):376.

19.

Anaphylaxis following quadrivalent human papillomavirus vaccination.

Brotherton JM, Gold MS, Kemp AS, McIntyre PB, Burgess MA, Campbell-Lloyd S; New South Wales Health HPV Adverse Events Panel.

CMAJ. 2008 Sep 9;179(6):525-33. doi: 10.1503/cmaj.080916. Epub 2008 Sep 1.

20.

Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program.

Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD.

Pediatrics. 2008 May;121(5):e1125-32. doi: 10.1542/peds.2007-1590.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk